Table 3.

Procedural characteristics and outcomes

Complete revascularisation	100% (14/14)
Duration of ECMO (h)	3 (1–4)
Limb ischaemia	0% (0/14)
Post-procedural admission to ICU	0% (0/14)
Thromboembolic complication	14% (2/14)
Renal insufficiency post-procedure (increase ≥1 stage above baseline)	21% (3/14)
Need for haemodialysis	0% (0/14)
Haemoglobin drop (mmol/l)	2.0 (0.4–3.0)
Thrombocyte drop ($\times {10}^9/\text{l}$)	82 (16–107)
MACE during admission	14% (2/14)
Re-infarction	7% (1/14)
Mortality at discharge	7% (1/14)

ECMO extracorporeal membrane oxygenation; ICU intensive care unit; MACE major adverse clinical events